Quick Answer
SkinHealth Systems Inc. reported Net Income Loss of -$9.52 million for the year ending 2025.
- SkinHealth Systems Inc. showed an increase of +67.3% in Net Income Loss from 2024 to 2025.
- This data is from SkinHealth Systems Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: -$9.07 million | Q2 2020: -$10.40 million | Q3 2020: -$2.21 million | Q1 2021: -$3.27 million | Q2 2021: -$139.38 million | Q3 2021: -$215.15 million | Q1 2022: $31.46 million | Q2 2022: $6.32 million | Q3 2022: -$81.0 thousand | Q1 2023: -$20.26 million | Q2 2023: $3.36 million | Q3 2023: -$73.82 million | Q1 2024: -$679.0 thousand | Q2 2024: $202.0 thousand | Q3 2024: -$18.29 million | Q1 2025: -$10.10 million | Q2 2025: $19.71 million | Q3 2025: -$11.03 million.
- Over the full 7 years of available data (2019 to 2025), SkinHealth Systems Inc.'s Net Income Loss has declined by 481.1%.
- Historical annual values: Fiscal year 2025: -$9.52 million | Fiscal year 2024: -$29.10 million | Fiscal year 2023: -$100.12 million | Fiscal year 2022: $44.22 million | Fiscal year 2021: -$378.76 million | Fiscal year 2020: -$29.18 million | Fiscal year 2019: -$1.64 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: